ConductScience.org, home

Paper2425199

Recurrence and survival after total mesorectal excision for rectal cancer.

Heald RJ and 1 other. Lancet, 1986. Cited by 2,112 papers, by iCite.

Cite this record

ConductScience Library. Recurrence and survival after total mesorectal excision for rectal cancer. Papers, record 2425199. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2425199

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Recurrence and survival after total mesorectal excision for rectal cancer.
PubMed
Journal
Lancet
PubMed
Year
1986
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
2,112
iCite
Relative citation ratio, by iCite
78.4
iCite
Revised in PubMed
2022-04-09
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Heald RJR J
2Ryall RDR D

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Rectal NeoplasmsMajor topic
RectumMajor topic
Follow-Up Studies
Humans
Methods
Neoplasm Recurrence, Local
Neoplasm Staging
Palliative Care
Postoperative Complications
Surgical Staplers

Source PubMed

Download CSV of topics

Trials11

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT00855946Proteomic Approach Using Matrix-assisted Laser Desorption/Ionization Tandem Time-of-flight (MALDI-TOF/TOF) of Tumor Response in Rectal Carcinoma After RadiochemotherapyBackgroundClinicalTrials.gov
NCT02465593A Study of PEP503(Radio-enhancer) With Radiotherapy and Chemotherapy for Patients With Rectal CancerBackgroundClinicalTrials.gov
NCT02843191Consolidation Chemotherapy for Locally Advanced Mid or Low Rectal Cancer After Neoadjuvant Concurrent ChemoradiotherapyBackgroundClinicalTrials.gov
NCT02943694The Feasibility and Safety of Instruments in Transanal Total Mesorectal Excision (TaTME) for Rectal CancerBackgroundClinicalTrials.gov
NCT02954913Simultaneous Resection of Colorectal Cancer With Synchronous Liver MetastasesBackgroundClinicalTrials.gov
NCT03351959Complete Pathologic Response Rectal CancersBackgroundClinicalTrials.gov
NCT03895255Selective sPlenic flExure Mobilization for Low colorEctal Anastomosis After D3 lYmph Node Dissection (Speedy Trial)ResultsClinicalTrials.gov
NCT04134104Incidence of The Bowel, Bladder, and Sexual Dysfunction Following Surgery for Colorectal MalignancyBackgroundClinicalTrials.gov
NCT04200027Robotic vs. TaTME Rectal Surgery (ROTA STUDY)BackgroundClinicalTrials.gov
NCT05136326Preoperative Chemoradiotherapy With CApecitabine and Temozolomide in MGMT Silenced, MSS, Locally Advanced RecTal CancerBackgroundClinicalTrials.gov
NCT07404228
Multidimensional Study Designed to Develop a Methodological Framework Based on MRI Data to Predict Pathological Complete Response (pCR) in Patients With Locally Advanced Rectal Cancer After Neoadjuvant Treatment
BackgroundClinicalTrials.gov

Download CSV of trials

Cited by870

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2,112 citations.

PMIDTitleJournalYearIn PapersSource
42875765Routine versus postoperative CRP/CT guided selective diverting ileostomy after laparoscopic low anterior resection for rectal cancer: a comparative randomized controlled trial.BMC Surg2026https://conductscience.org/library/papers/42875765PubMed
42834699A systematic review and meta-analysis of preoperative MRI-based pelvimetry in predicting surgical difficulty in rectal cancer: Implications for personalised surgical planning.Colorectal Dis2026https://conductscience.org/library/papers/42834699PubMed
42720902Nonlinear association between number of lymph nodes resected and survival in T1N0M0 colorectal cancer: a SEER-based analysis.Updates Surg2026https://conductscience.org/library/papers/42720902PubMed
42704036The role of particle therapy in the treatment of locally recurrent rectal cancer: a systematic review.Radiol Oncol2026https://conductscience.org/library/papers/42704036PubMed
42698441Deep learning-assisted near-real-time identification of the inferior mesenteric artery and vein during laparoscopic rectal resection: a single-center proof-of-concept study.Front Med (Lausanne)2026https://conductscience.org/library/papers/42698441PubMed
42682280Artificial intelligence real-time overall recognition model for total mesorectal excision.Int J Surg2026https://conductscience.org/library/papers/42682280PubMed
42621528Synchronous Nasopharyngeal Carcinoma and Rectal Adenocarcinoma Treated With Integrated Multimodal Therapy: A Case Report and Literature Review.Cureus2026https://conductscience.org/library/papers/42621528PubMed
42477736Advances in predictive factors for pathological complete response after neoadjuvant therapy in locally advanced rectal cancer.Radiat Oncol2026https://conductscience.org/library/papers/42477736PubMed
42441088Efficacy of adjuvant chemotherapy in patients with late-onset stage II/III colon cancer: a retrospective cohort study.Open Med (Wars)2026https://conductscience.org/library/papers/42441088PubMed
42437419Digital rectal examination in rectal cancer response assessment: clinical performance and the need for standardized reporting.Tech Coloproctol2026https://conductscience.org/library/papers/42437419PubMed
42396616Rethinking lymphadenectomy in the immunotherapy era of colorectal cancer: A hypothesis-generating perspective.Colorectal Dis2026https://conductscience.org/library/papers/42396616PubMed
42360525Predicting anatomical difficulty in robot-assisted rectal resection using a novel anatomic landmark-based grading system: a prospective observational study.Tech Coloproctol2026https://conductscience.org/library/papers/42360525PubMed
42307785Tumor regression pattern and distribution of residual tumor cells in potential candidates for local excision of rectal cancer: a prospective cohort study.Tech Coloproctol2026https://conductscience.org/library/papers/42307785PubMed
42266123Margin-driven outcomes prevail over resection planes: multivisceral surgery matches total mesorectal excision in locally advanced rectal cancer.Ann Coloproctol2026https://conductscience.org/library/papers/42266123PubMed
42255982MESORECT : Influence of bladder depletion on mesorectal movements during radiation therapy of locally advanced rectal cancers: a prospective comparative study.Clin Transl Radiat Oncol2026https://conductscience.org/library/papers/42255982PubMed
42223567Resection quality and oncologic outcomes after robotic versus laparoscopic total mesorectal excision for mid and low rectal cancer: a systematic review and meta-analysis of randomised trials.J Robot Surg2026https://conductscience.org/library/papers/42223567PubMed
42206822Short-term outcomes in robotic-assisted versus conventional laparoscopic surgery for rectal cancer: population-based study.BJS Open2026https://conductscience.org/library/papers/42206822PubMed
42199895The right hemicolon fascial system: a narrative review.Front Surg2026https://conductscience.org/library/papers/42199895PubMed
42187894Total Neoadjuvant Therapy, Organ Preservation and Beyond: A State-of-the-Art Systematic Review and Critical Appraisal of Locally Advanced Rectal Cancer Management.Diseases2026https://conductscience.org/library/papers/42187894PubMed
42121646Quality of Life and Functional Outcomes After Rectal Cancer Surgery: A Comparative Study Applying EORTC QLQ-C30, QLQ-CR29, and LARS Score at 1-6 Months Postoperatively.Healthcare (Basel)2026https://conductscience.org/library/papers/42121646PubMed

See all 870 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2425199

GET https://conductscience.org/api/papers/v1/2425199/cited_by?page=2